ABIO Annual Non Current Assets
$430.00 K
+$44.00 K+11.40%
31 December 2023
Summary:
As of February 4, 2025, ABIO annual long term assets is $430.00 thousand, with the most recent change of +$44.00 thousand (+11.40%) on December 31, 2023. During the last 3 years, it has fallen by -$31.00 thousand (-6.72%).ABIO Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Quarterly Non Current Assets
$24.00 K
-$12.00 K-33.33%
30 June 2024
Summary:
As of February 4, 2025, ABIO quarterly long term assets is $24.00 thousand, with the most recent change of -$12.00 thousand (-33.33%) on June 30, 2024. Over the past year, it has dropped by -$245.00 thousand (-91.08%).ABIO Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABIO Non Current Assets Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +11.4% | -91.1% |
3 y3 years | -6.7% | -95.4% |
5 y5 years | +795.8% | -95.4% |
ABIO Non Current Assets High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | -98.2% | -99.9% |
ARCA Biopharma Non Current Assets History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | $24.00 K(-33.3%) |
Mar 2024 | - | $36.00 K(-86.6%) |
Dec 2023 | $37.43 M(-12.3%) | $269.00 K(-7.9%) |
Sept 2023 | - | $292.00 K(-11.0%) |
June 2023 | - | $328.00 K(-8.1%) |
Mar 2023 | - | $357.00 K(-7.5%) |
Dec 2022 | $42.70 M(-21.5%) | $386.00 K(-7.0%) |
Sept 2022 | - | $415.00 K(-7.0%) |
June 2022 | - | $446.00 K(-6.1%) |
Mar 2022 | - | $475.00 K(-5.6%) |
Dec 2021 | $54.42 M(+8.9%) | $503.00 K(-4.4%) |
Sept 2021 | - | $526.00 K(-3.5%) |
June 2021 | - | $545.00 K(+20.3%) |
Mar 2021 | - | $453.00 K(-1.7%) |
Dec 2020 | $49.97 M(+489.2%) | $461.00 K(+902.2%) |
Sept 2020 | - | $46.00 K(-23.3%) |
June 2020 | - | $60.00 K(-27.7%) |
Mar 2020 | - | $83.00 K(+48.2%) |
Dec 2019 | $8.48 M(+25.1%) | $56.00 K(+24.4%) |
Sept 2019 | - | $45.00 K(-30.8%) |
June 2019 | - | $65.00 K(-25.3%) |
Mar 2019 | - | $87.00 K(+81.3%) |
Dec 2018 | $6.78 M(-44.9%) | $48.00 K(-9.4%) |
Sept 2018 | - | $53.00 K(-7.0%) |
June 2018 | - | $57.00 K(-6.6%) |
Mar 2018 | - | $61.00 K(-7.6%) |
Dec 2017 | $12.30 M(-42.6%) | $66.00 K(-87.9%) |
Sept 2017 | - | $545.00 K(-15.0%) |
June 2017 | - | $641.00 K(-12.8%) |
Mar 2017 | - | $735.00 K(-76.9%) |
Dec 2016 | $21.45 M(-44.9%) | $3.18 M(-34.9%) |
Sept 2016 | - | $4.89 M(-17.1%) |
June 2016 | - | $5.90 M(-0.2%) |
Mar 2016 | - | $5.91 M(+798.2%) |
Dec 2015 | $38.92 M(+151.3%) | $658.00 K(-7.3%) |
Sept 2015 | - | $710.00 K(-9.9%) |
June 2015 | - | $788.00 K(+34.2%) |
Mar 2015 | - | $587.00 K(-8.9%) |
Dec 2014 | $15.49 M(-8.5%) | $644.00 K(+12.2%) |
Sept 2014 | - | $574.00 K(-33.3%) |
June 2014 | - | $860.00 K(+0.7%) |
Mar 2014 | - | $854.00 K(+437.1%) |
Dec 2013 | $16.93 M(+455.8%) | $159.00 K(+25.2%) |
Sept 2013 | - | $127.00 K(+1.6%) |
June 2013 | - | $125.00 K(-14.4%) |
Mar 2013 | - | $146.00 K(-12.6%) |
Dec 2012 | $3.04 M(-51.0%) | $167.00 K(-15.2%) |
Sept 2012 | - | $197.00 K(-12.8%) |
June 2012 | - | $226.00 K(-11.7%) |
Mar 2012 | - | $256.00 K(-11.7%) |
Dec 2011 | $6.21 M(-13.3%) | $290.00 K(-29.3%) |
Sept 2011 | - | $410.00 K(-45.6%) |
June 2011 | - | $754.00 K(-15.2%) |
Mar 2011 | - | $889.00 K(-10.6%) |
Dec 2010 | $7.16 M | $994.00 K(+20.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2010 | - | $828.00 K(-9.6%) |
June 2010 | - | $916.00 K(-8.6%) |
Mar 2010 | - | $1.00 M(-29.1%) |
Dec 2009 | $7.96 M(-17.8%) | $1.41 M(-80.4%) |
Sept 2009 | - | $7.23 M(-50.3%) |
June 2009 | - | $14.55 M(-1.7%) |
Mar 2009 | - | $14.81 M(+956.8%) |
Dec 2008 | $9.68 M(-90.3%) | $1.40 M(-90.3%) |
Sept 2008 | - | $14.48 M(-3.7%) |
June 2008 | - | $15.04 M(-25.6%) |
Mar 2008 | - | $20.23 M(-2.3%) |
Dec 2007 | $99.99 M(-39.9%) | $20.70 M(-2.7%) |
Sept 2007 | - | $21.26 M(+34.2%) |
June 2007 | - | $15.84 M(-9.4%) |
Mar 2007 | - | $17.49 M(-3.2%) |
Dec 2006 | $166.34 M(+93.9%) | $18.07 M(-21.0%) |
Sept 2006 | - | $22.86 M(+1.6%) |
June 2006 | - | $22.51 M(+0.1%) |
Mar 2006 | - | $22.49 M(+0.9%) |
Dec 2005 | $85.77 M(+30.0%) | $22.28 M(+2.3%) |
Sept 2005 | - | $21.78 M(+22.0%) |
June 2005 | - | $17.85 M(+39.0%) |
Mar 2005 | - | $12.84 M(-3.2%) |
Dec 2004 | $66.00 M(+65.6%) | $13.27 M(-10.0%) |
Sept 2004 | - | $14.74 M(-7.8%) |
June 2004 | - | $15.99 M(-5.6%) |
Mar 2004 | - | $16.94 M(-5.6%) |
Dec 2003 | $39.86 M(+577.6%) | $17.95 M(-9.1%) |
Sept 2003 | - | $19.74 M(-0.0%) |
June 2003 | - | $19.75 M(-17.5%) |
Mar 2003 | - | $23.93 M(+12.9%) |
Dec 2002 | $5.88 M(-63.9%) | $21.19 M(+5.3%) |
Sept 2002 | - | $20.13 M(-8.3%) |
June 2002 | - | $21.96 M(-4.3%) |
Mar 2002 | - | $22.95 M(-2.8%) |
Dec 2001 | $16.30 M(+189.7%) | $23.60 M(+21.1%) |
Sept 2001 | - | $19.50 M(+7.2%) |
June 2001 | - | $18.19 M(+4.2%) |
Mar 2001 | - | $17.46 M(+11.5%) |
Dec 2000 | $5.63 M(-82.9%) | $15.66 M(+2.6%) |
Sept 2000 | - | $15.27 M(+12.5%) |
June 2000 | - | $13.57 M(+14.8%) |
Mar 2000 | - | $11.82 M(-4.7%) |
Dec 1999 | $33.00 M(-31.5%) | $12.40 M(+5.1%) |
Sept 1999 | - | $11.80 M(+11.3%) |
June 1999 | - | $10.60 M(+2.9%) |
Mar 1999 | - | $10.30 M(+6.2%) |
Dec 1998 | $48.20 M(-19.9%) | $9.70 M(0.0%) |
Sept 1998 | - | $9.70 M(+11.5%) |
June 1998 | - | $8.70 M(+11.5%) |
Mar 1998 | - | $7.80 M(+14.7%) |
Dec 1997 | $60.20 M(+736.1%) | $6.80 M(+78.9%) |
Sept 1997 | - | $3.80 M(+11.8%) |
June 1997 | - | $3.40 M(+54.5%) |
Mar 1997 | - | $2.20 M |
Dec 1996 | $7.20 M | - |
FAQ
- What is ARCA biopharma annual long term assets?
- What is the all time high annual non current assets for ARCA biopharma?
- What is ARCA biopharma annual non current assets year-on-year change?
- What is ARCA biopharma quarterly long term assets?
- What is the all time high quarterly non current assets for ARCA biopharma?
- What is ARCA biopharma quarterly non current assets year-on-year change?
What is ARCA biopharma annual long term assets?
The current annual non current assets of ABIO is $430.00 K
What is the all time high annual non current assets for ARCA biopharma?
ARCA biopharma all-time high annual long term assets is $23.60 M
What is ARCA biopharma annual non current assets year-on-year change?
Over the past year, ABIO annual long term assets has changed by +$44.00 K (+11.40%)
What is ARCA biopharma quarterly long term assets?
The current quarterly non current assets of ABIO is $24.00 K
What is the all time high quarterly non current assets for ARCA biopharma?
ARCA biopharma all-time high quarterly long term assets is $23.93 M
What is ARCA biopharma quarterly non current assets year-on-year change?
Over the past year, ABIO quarterly long term assets has changed by -$245.00 K (-91.08%)